Shanghai Chemspec Corporation, together with its subsidiaries, engages in the research, development, production, and sale of fine chemicals in China and interna...
Chemspec Europe Returns to Cologne in May 2026
Chemspec shareholders reduced their holdings, and after the change in equity, their shareholding decreased to 5%
CRO concept stocks fluctuate and rise, Jiuzhou Pharma hits the limit up
Chemspec released its semi-annual performance, with a net profit attributable to the parent company of 31.02 million yuan, a year-on-year increase of 257.08%
Multiple shareholders of Chemspec plan to reduce their holdings by no more than 5.89%
Overview of the lifting of restrictions on the sale of A-shares | July 21